Drug Topics September 1, 2025
Brian Nowosielski

After sharing his son’s tragic story, Bil Schmidtknecht discusses the common ways the Big 3 PBMs operate and how smaller organizations are on the rise, becoming unlikely competitors.

With new and emerging pharmacy benefit managers (PBM) in the prescription drug supply chain, competition within the market has been unprecedented as of late. Highlighting the key differences between the ways in which large and small PBMs operate within the market, experts believe emerging PBMs have the potential to enforce indefinite change in the way prescription drug benefits are administered in the US.

“[The Big 3 PBMs] are involved in government programs; the little guys usually don’t get shots at that,” Bil Schmidtknecht, founder of Patient Protector and director of patient experience...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Interview / Q&A, Pharma, Pharma / Biotech, Trends
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety

Share Article